Literature DB >> 11361058

Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer.

K T Cheon1, K H Choi, H B Lee, S K Park, Y K Rhee, Y C Lee.   

Abstract

The objectives of this study were to examine the possible involvement of endothelial nitric oxide synthase (ecNOS) and angiotensin-converting enzyme (ACE) genes in the genetic basis of lung cancer. Two hundred eighteen patients with lung cancer and 121 healthy subjects were included in this study. The ecNOS and ACE genotypes were determined in all subjects by polymerase chain reaction. The distribution of genotypes of ecNOS gene was significantly different in the lung cancer group than in the control population. ACE genotype distribution was not significantly different in the lung cancer group compared with the control group. These results suggest that polymorphisms of the ecNOS gene, but not the ACE gene, may be associated with the development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11361058     DOI: 10.1007/s004080000039

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  14 in total

1.  RETRACTED: Association of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism With Lung Cancer Susceptibility.

Authors:  Xiao-Neng Mo; Ri-Wen Yang; Feng Zhang; Yu Dong; Zi-Wen Zhao
Journal:  Technol Cancer Res Treat       Date:  2016-06-23

2.  Endothelial nitric oxide synthase intron 4 VNTR gene polymorphisms in European and African populations.

Authors:  Alfredo Santovito; Piero Cervella; Massimiliano Delpero
Journal:  Mol Biol Rep       Date:  2012-03-16       Impact factor: 2.316

Review 3.  Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis.

Authors:  Kan Zhang; Dan Cheng; Lingling Yi; Huimin Shi; Guohua Zhen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis.

Authors:  Yonggang Zhang; Jie He; Yao Deng; Jie Zhang; Xiaobo Li; Zhangpeng Xiang; Honglang Huang; Can Tian; Jin Huang; Hong Fan
Journal:  BMC Med Genet       Date:  2011-12-12       Impact factor: 2.103

5.  No association of the eNOS gene polymorphisms with survival in patients with colorectal cancer.

Authors:  Yun Jeong Kim; Soo Jung Lee; Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Joon Ho Moon; Byung Woog Kang; Jin Young Park; Jun Seok Park; Gyu Seog Choi
Journal:  Med Oncol       Date:  2010-08-13       Impact factor: 3.064

6.  Prognostic significance of three endothelial nitric oxide synthase (eNOS) polymorphisms and metabolic syndrome (MetS) in patients with colorectal cancer.

Authors:  Eun Ju Ko; Eo Jin Kim; Hye Jung Cho; Jisu Oh; Han Sung Park; Chang Soo Ryu; Jung Oh Kim; Hak Hoon Jun; So Young Chong; Jong Woo Kim; Nam Keun Kim
Journal:  Genes Genomics       Date:  2022-04-04       Impact factor: 2.164

7.  Association of endothelial nitric oxide synthase gene polymorphisms with endometrial carcinoma: a preliminary study.

Authors:  Ebru Oztürk; Ebru Dikensoy; Ozcan Balat; Mete Gürol Uğur; Sibel Oğuzkan Balcı; Abdullah Aydın; Ulkü Kazancı; Sacide Pehlivan
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01

8.  An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer.

Authors:  Chih-Ching Yeh; Regina M Santella; Ling-Ling Hsieh; Fung-Chang Sung; Reiping Tang
Journal:  Int J Cancer       Date:  2009-04-01       Impact factor: 7.396

9.  An updated meta-analysis on association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer risk.

Authors:  Yuebing Xie; Chao You; Jing Chen
Journal:  Tumour Biol       Date:  2014-04-03

10.  Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer.

Authors:  Zafer Bayraktutan; Ahmet Kiziltunc; Ebubekir Bakan; Hamit Hakan Alp
Journal:  Eurasian J Med       Date:  2020-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.